Standard ways of assessing depression risk may not work as well among black adults as white adults, according to the results of a long-term study.
A new study finds that standard ways of assessing depression risk may not work as well among black adults as white adults. The study, published Frontiers in Public Health, presents results from a new analysis of long-term data from the Americans’ Changing Lives study.
Investigators Ehsan Moazen-Zadeh, MD, of the Medicine and Health Promotion Institute in Tehran, Iran, and Shervin Assari, MD, MPH, of the University of Michigan, studied 2205 white adults and 1156 black adults who took a standard depression screening test, the Center for Epidemiologic Studies Depression Scale (CES-D), at the beginning of their involvement in the study.
Fifteen years later, the subjects underwent a much more detailed interview meant to assess their mental health, and investigators compared the association between depressive symptoms and subsequent risk of Major Depressive Disorder (MDD) among black and white study subjects. Worldwide, MDD is among the 4 conditions with the highest contribution to years of life lost due to disability.
The CES-D is one of the most widely used survey instruments, asking a range of questions about emotions, appetite, sleep, and energy levels. The question of whether the CES-D provides comparable results for whites and blacks in clinical and community settings has been the subject of debate, with some studies implying that CES-D scores may differently represent true depression in whites and blacks.
Although study subjects who scored high on depressive symptoms at the beginning of the study were, in fact, more likely to meet the definition of having MDD at the later date, the research yielded a surprise: white participants whose answers on the initial screening suggested a risk for depression were more likely to have MDD at the time of the later interview. But this was not the case for black study subjects, and the difference remained even after the researchers corrected for differences in participants’ social, economic, and physical health.
For black participants, the factor that did seem to predict later depression was study subjects’ self-rated health. Blacks whose self-reported health status was worse at the start were more likely to have MDD 15 years later on.
Dr Assari noted that their findings question the universal applicability of a tool that has been developed and validated for whites.
“The results also have major implications for screening and treatment of depression in black communities,” he said.
The authors said their work does not undercut the validity of the CES-D in measuring the risk of depression reliably: the test was more reliable in blacks than whites at each time point, but its use in predicting long-term risk of depression in blacks may be lower.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More